Burke, J. M., Nigris, E. D., Wang, Y., Aguilar, K., Murphy, J., Wayne, B., Prescott, J., Chirovsky, D., Kim, I., Leng, S., Zackon, I. (2025). Correlation between real-world (RW) progression-free survival (rwPFS) and overall survival (OS) among patients (Pts) with first-line (1L) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) receiving covalent bruton tyrosine kinase inhibitors (cBTKis) or B-cell lymphoma 2 inhibitors (BCL2is). Blood. https://doi.org/10.1182/blood-2025-3888